Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309 - PubMed (original) (raw)
Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309
M Inngjerdingen et al. J Immunol. 2000.
Abstract
NK cells respond to various chemokines, suggesting that they express receptors for these chemokines. In this paper, we show that IL-2-activated NK (IANK) cells express CC chemokine receptor 4 (CCR4) and CCR8, as determined by flow cytometric, immunoblot, and RNase protection assays. Macrophage-derived chemokine (MDC), the ligand for CCR4, induces the phosphorylation of CCR4 within 0.5 min of activating IANK cells with this ligand. This is corroborated with the recruitment of G protein-coupled receptor kinases 2 and 3 and their association with CCR4 in IANK cell membranes. Also, CCR4 is internalized between 5 and 45 min but reappears in the membranes after 60 min of stimulation with MDC. MDC, thymus and activation-regulated chemokine (TARC), and I-309 induce the chemotaxis of IANK cells, an activity that is inhibited upon pretreatment of these cells with pertussis toxin, suggesting that receptors for these chemokines are coupled to pertussis toxin-sensitive G proteins. In the calcium release assay, cross-desensitization experiments showed that TARC completely desensitizes the calcium flux response induced by MDC or I-309, whereas both MDC and I-309 partially desensitize the calcium flux response induced by TARC. These results suggest that TARC utilizes CCR4 and CCR8. Our results are the first to show that IL-2-activated NK cells express CCR4 and CCR8, suggesting that these receptors are not exclusive for Th2 cells.
Similar articles
- Inhibition by IL-12 and IFN-alpha of I-309 and macrophage-derived chemokine production upon TCR triggering of human Th1 cells.
Iellem A, Colantonio L, Bhakta S, Sozzani S, Mantovani A, Sinigaglia F, D'Ambrosio D. Iellem A, et al. Eur J Immunol. 2000 Apr;30(4):1030-9. doi: 10.1002/(SICI)1521-4141(200004)30:4<1030::AID-IMMU1030>3.0.CO;2-8. Eur J Immunol. 2000. PMID: 10760790 - Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4.
Imai T, Chantry D, Raport CJ, Wood CL, Nishimura M, Godiska R, Yoshie O, Gray PW. Imai T, et al. J Biol Chem. 1998 Jan 16;273(3):1764-8. doi: 10.1074/jbc.273.3.1764. J Biol Chem. 1998. PMID: 9430724 - Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells.
Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, D'Ambrosio D. Iellem A, et al. J Exp Med. 2001 Sep 17;194(6):847-53. doi: 10.1084/jem.194.6.847. J Exp Med. 2001. PMID: 11560999 Free PMC article. - Antichemokine immunotherapy for allergic diseases.
Luster AD. Luster AD. Curr Opin Allergy Clin Immunol. 2001 Dec;1(6):561-7. doi: 10.1097/00130832-200112000-00012. Curr Opin Allergy Clin Immunol. 2001. PMID: 11964742 Review. - New chemokine targets for asthma therapy.
Garcia G, Godot V, Humbert M. Garcia G, et al. Curr Allergy Asthma Rep. 2005 Mar;5(2):155-60. doi: 10.1007/s11882-005-0090-0. Curr Allergy Asthma Rep. 2005. PMID: 15683617 Review.
Cited by
- Identification of a non-canonical chemokine-receptor pathway suppressing regulatory T cells to drive atherosclerosis.
Döring Y, van der Vorst EPC, Yan Y, Neideck C, Blanchet X, Jansen Y, Kemmerich M, Bayasgalan S, Peters LJF, Hristov M, Bidzhekov K, Yin C, Zhang X, Leberzammer J, Li Y, Park I, Kral M, Nitz K, Parma L, Gencer S, Habenicht A, Faussner A, Teupser D, Monaco C, Holdt L, Megens RTA, Atzler D, Santovito D, von Hundelshausen P, Weber C. Döring Y, et al. Nat Cardiovasc Res. 2024 Feb 1;3:221-242. doi: 10.1038/s44161-023-00413-9. Epub 2024 Jan 22. Nat Cardiovasc Res. 2024. PMID: 39044999 Free PMC article. - C-C chemokine receptor 5 is essential for conventional NK cell trafficking and liver injury in a murine hepatitis virus-induced fulminant hepatic failure model.
Liu YH, Zhu L, Zhang ZW, Liu TT, Cheng QY, Zhang M, Niu YX, Ding L, Yan WM, Luo XP, Ning Q, Chen T. Liu YH, et al. J Transl Med. 2023 Nov 29;21(1):865. doi: 10.1186/s12967-023-04665-8. J Transl Med. 2023. PMID: 38017505 Free PMC article. - Chemokine Receptor-Targeted Therapies: Special Case for CCR8.
Moser B. Moser B. Cancers (Basel). 2022 Jan 20;14(3):511. doi: 10.3390/cancers14030511. Cancers (Basel). 2022. PMID: 35158783 Free PMC article. Review. - Skin-resident dendritic cells mediate postoperative pain via CCR4 on sensory neurons.
Silva JR, Iftinca M, Fernandes Gomes FI, Segal JP, Smith OMA, Bannerman CA, Silva Mendes A, Defaye M, Robinson MEC, Gilron I, Cunha TM, Altier C, Ghasemlou N. Silva JR, et al. Proc Natl Acad Sci U S A. 2022 Jan 25;119(4):e2118238119. doi: 10.1073/pnas.2118238119. Proc Natl Acad Sci U S A. 2022. PMID: 35046040 Free PMC article. - Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones?
Karin N. Karin N. Cancers (Basel). 2021 Dec 16;13(24):6317. doi: 10.3390/cancers13246317. Cancers (Basel). 2021. PMID: 34944943 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases